1-2 of 2
Hailing Lu, PhD
Close
Sort by
Journal Articles

Long Term Follow-up of a Phase 2 Study Examining Intratumoral G100 Alone and in Combination with Pembrolizumab in Patients with Follicular Lymphoma

Christopher R Flowers, MD MS, Carlos Panizo, MD PhD, Iris Isufi, MD, Alex F. Herrera, MD, Craig Okada, MD PhD, Elizabeth H. Cull, MD, Bela Kis, MD, Jorge M. Chaves, MD, Nancy L. Bartlett, MD, Weiyun Ai, MD PhD, Luis de la Cruz-Merino, MD PhD, Locke J. Bryan, MD, Roch Houot, MD PhD, Kim Linton, MBChB PhD, Javier Briones, MD, Ian Chau, MD, Gottfried R. von Keudell, MD PhD, Hailing Lu, PhD, Frank J Hsu, MD, Ahmad S Halwani, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2892.
https://doi.org/10.1182/blood-2018-99-117932
Published: 2018
Journal Articles

Intratumoral G100 Induces Systemic Immunity and Abscopal Tumor Regression in Patients with Follicular Lymphoma: Results of a Phase 1/ 2 Study Examining G100 Alone and in Combination with Pembrolizumab

Christopher Flowers, MD, Carlos Panizo, MD PhD, Iris Isufi, MD, Alex F. Herrera, MD, Craig Okada, MD PhD, Elizabeth H. Cull, MD, Bela Kis, MD, Jorge M. Chaves, MD, Nancy L. Bartlett, MD, Weiyun Ai, MD PhD, Luis de la Cruz-Merino, MD, Locke J. Bryan, MD, Roch Houot, MD PhD, Kim Linton, MBChB PhD, Javier Briones, MD, Ian Chau, MD, Gottfried R. von Keudell, MD PhD, Hailing Lu, PhD, Frank J Hsu, MD, Ahmad S. Halwani, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2771.
https://doi.org/10.1182/blood.V130.Suppl_1.2771.2771
Published: 2017